Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Research and development - MRTP

Sales, general and administrative

Impairment of intangible assets

Depreciation

Amortization

Other operating expense, net

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

22nd Century Group

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

22nd Century Group advances VLN and GVB units towards profitability

22nd Century Group's Q4 2022 earnings call highlighted progress in VLN tobacco and GVB hemp/cannabis units, with plans for multi-state launches and cash positive operations in 2024. Despite challenges like the Grass Valley facility fire, the company remains focused on achieving profitability through revenue growth and market expansion. Key strengths include successful pilot results, volume growth, and a clear path to cash positivity for both business units.

22nd Century Group (XXII) reports strong Q1 performance and growth strategies

22nd Century Group (XXII) showcases strong performance and strategic initiatives to drive revenue growth and achieve cash positivity by 2024.
Despite challenges such as analyst inquiries and insurance impacts, the company's focus on cost efficiencies and margin improvements positions it for success.
Opportunities in revenue growth, bulk ingredient capacity expansion, and margin enhancements present promising prospects for future profitability and market growth.

22nd Century Group reports strong Q2 performance amidst operational challenges

22nd Century Group's Q2 performance showcased growth in sales but faced challenges in gross profit due to production mix shifts.
The company's proactive strategies for cost savings, brand value creation, and gross margin improvement indicate a focus on long-term sustainability.
Despite challenges like VLN rollout delays and tobacco business hurdles, opportunities in market differentiation and efficiency improvements are being pursued.

22nd Century Group pursues profitability through strategic shifts and cost management

22nd Century Group's Q4 2023 earnings call highlighted efforts to achieve profitability by reducing cash burn, focusing on VLN cigarettes for harm reduction, and exploring CMO opportunities in tobacco manufacturing. Despite challenges like decreased net sales and a negative gross profit, the company aims to reach breakeven by Q1 2025.

22nd Century Group reduces cash burn, aims for profitability by 2025

22nd Century Group's Q1 2024 performance reflects progress towards profitability, with improved financial discipline and operational efficiency.
While facing revenue challenges and legal disputes, the company's strategic initiatives and investor support position it for future growth and success.
The focus on reducing losses, strengthening the balance sheet, and expanding market presence underscores the company's commitment to long-term sustainability.

22nd Century Group reports Q2 financial turnaround and growth strategies

22nd Century Group's Q2 2024 performance reflects a notable financial turnaround and progress towards profitability.
Strategic initiatives, leadership appointments, and product strategies position the company for future growth and success.
While challenges remain in achieving cash positive operations, opportunities in market expansion and product innovation offer avenues for continued advancement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises. Financing Provides Support to the Company's Strategic Objectives Across All Its Plant Franchises.

22nd Century Announces $40 Million Common Stock Registered Direct Offering

22nd Century Group, Inc. (NYSE:XXII) is a plant biotechnology company covering the tobacco, hemp and cannabis markets. “At our core, think of us as the Intel Inside of cannabis.

22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics

BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021:

22nd Century to Participate in May and June 2021 Investor Conferences

Seelos Therapeutics

US Well Services

Top penny stocks in 2021? Check these 3 out for some watchlist inspiration The post Best Penny Stocks to Invest in 2021?

Best Penny Stocks to Invest in 2021? Here's 3 To Check Out

Allied Esports Entertainment Inc

American Resources Corp

Centennial Resource Development

Cinedigm

SNDL Inc.

Support.com

Uranium Energy

Looming uncertainty may be bad news for most Reddit penny stocks, but these eight may hold onto their gains, or head higher, from here. The post 8 Reddit Penny Stocks That May Withstand the Market Maelstrom appeared first on InvestorPlace.

8 Reddit Penny Stocks That May Withstand the Market Maelstrom

Research Shows Cigarette Addiction Disproportionately Harms Minority and Vulnerable Communities; Mandating Reduced Nicotine Content in Cigarettes Would Help Counteract Years of Targeted Marketing of Addictive and Deadly Products by Big Tobacco Research Shows Cigarette Addiction Disproportionately Harms Minority and Vulnerable Communities; Mandating Reduced Nicotine Content in Cigarettes Would Help Counteract Years of Targeted Marketing of Addictive and Deadly Products by Big Tobacco

22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference

Cellect Biotechnology Ltd

Atossa Genetics

Evofem Biosciences Inc

Looking for the best penny stocks in May 2021? Check these 5 out The post 5 Hot Penny Stocks To Buy?

5 Hot Penny Stocks To Buy? Check These Out For May 2021

Arena Pharmaceuticals

GW Pharmaceuticals

HEXO Corp

FSD Pharma

Innovative Industrial Properties

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

Tilray Brands

cbdMD Inc

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in 2021.

What Happened with Marijuana Stocks This Week?

Pixelworks

Are these the hottest penny stocks to watch this week? That's for you to decide The post Hot Penny Stocks To Buy This Week?

Hot Penny Stocks To Buy This Week? 3 That Could Make Your Watchlist

22nd Century Group, Inc. (XXII) CEO Jim Mish on Q1 2021 Results - Earnings Call Transcript

22nd Century (XXII) delivered earnings and revenue surprises of 0.00% and -6.12%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

22nd Century Group (XXII) Reports Q1 Loss, Misses Revenue Estimates

22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021

Investment in New Lab Capabilities Will Reduce Testing Costs by 90% and Improve Turnaround Time from Weeks to Hours Investment in New Lab Capabilities Will Reduce Testing Costs by 90% and Improve Turnaround Time from Weeks to Hours

22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production

Updated Agreement Extends Exclusive Program to Create Valuable, New Hemp/Cannabis Varieties and Expands Collaboration to Include 22nd Century's Two Other Plant Franchises

22nd Century Group and KeyGene Extend and Expand Plant Research Partnership

Aphria

Akerna Corp

Philip Morris

Pyxus International Inc

These 10 Pot Stocks Smoked the Last Week of April

Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation and Reduced Disparities; Movement on Nicotine Cap by FDA Expected to be Forthcoming

22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”

The same old story could have a different ending this time for investors.

An Upcoming FDA Decision on Nicotine Could Send This Stock Soaring

When Mandate is Implemented, 22nd Century is Fully Prepared to Deliver VLN® Reduced Nicotine Content Cigarette, the Only Combustible Product in Line with FDA's Proposed Nicotine Cap When Mandate is Implemented, 22nd Century is Fully Prepared to Deliver VLN® Reduced Nicotine Content Cigarette, the Only Combustible Product in Line with FDA's Proposed Nicotine Cap

Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities

To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for Numerous Independent Scientific Studies

22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies

Canopy Growth

Corbus Pharmaceuticals Holdings

Neptune Wellness Solutions Inc.

Turning Point Brands

Village Farms International

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will continue to develop in the 2021.

4/20 Holiday Week Had These Cannabis Stocks Fired Up

BUFFALO, N.Y., April 22, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco and hemp/cannabis research, will host a live audio webcast on Thursday, May 6, 2021, at 10:00 AM ET to discuss its 2021 first quarter results. 22nd Century will report the Company's first quarter 2021 results in a press release at 6:00 AM ET the same day.

22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results

Company's Confidence in MRTP Authorization is High; Launch of VLN® is Only the Beginning for Tobacco Franchise

22nd Century Group Issues Annual Letter to Shareholders

9 Meters Biopharma

Liquid Media Group Ltd

Penny stocks continue to trend; which should you add to your watchlist? The post 3 Penny Stocks For Your ‘Doge Day' Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks For Your ‘Doge Day' Watchlist

Toughbuilt Industries Inc

Tonix Pharmaceuticals Hld

Torchlight Energy Resources

Finding trending penny stocks can be a great place to start making a watchlist; here's 3 to consider The post 4 Trending Penny Stocks to Watch on Monday, April 19th appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Trending Penny Stocks to Watch on Monday, April 19th

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry will continue to develop in the 2021.

5 Red-Hot Pot Stocks That Made Headlines This Week

News for 22nd Century Group Stock (XXII)